Louis Libbrecht
ORCID: 0000-0002-9453-3355
· 2 papers in corpus
BACKGROUND: Microarray technology has allowed to molecularly characterize many different cancer sites. This technology has the potential to individualize therapy and to discover new drug targets. However, due to technological differences an…